The immune checkpoint TIGIT is upregulated on T cells during bacterial infection and is a potential target for immunotherapy
Immunology & Cell Biology · 2024
DOI: 10.1111/imcb.12794 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunology & Cell Biology, 2024. Verfasst von Timothy R McCulloch und 12 weiteren Autor:innen. Beteiligte Einrichtung: Frazer Institute, Faculty of Medicine, The University of Queensland, Woolloongabba, QLD, Australia. Hauptthemen laut MEDLINE: Receptors, Immunologic, Immunotherapy, Mice, Inbred C57BL, Up-Regulation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, Diamantina Institute, University of Queensland.
Abstract (Originalsprache)
Antibiotic resistance is a major public health threat, and alternatives to antibiotic therapy are urgently needed. Immunotherapy, particularly the blockade of inhibitory immune checkpoints, is a leading treatment option in cancer and autoimmunity. In this study, we used a murine model of Salmonella Typhimurium infection to investigate whether immune checkpoint blockade could be applied to bacterial infection. We found that the immune checkpoint T‐cell immunoglobulin and ITIM domain (TIGIT) was significantly upregulated on lymphocytes during infection, particularly on CD4 + T cells, drastically limiting their proinflammatory function. Blockade of TIGIT in vivo using monoclonal antibodies was able to enhance immunity and improve bacterial clearance. The efficacy of anti‐TIGIT was dependent on the capacity of the antibody to bind to Fc (fragment crystallizable) receptors, giving important insights into the mechanism of anti‐TIGIT therapy. This research suggests that targeting immune checkpoints, such as TIGIT, has the potential to enhance immune responses toward bacteria and restore antibacterial treatment options in the face of antibiotic resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Frazer Institute, Faculty of Medicine, The University of Queensland, Woolloongabba, QLD, Australia.
- Australian Institute of Tropical Health and Medicine, James Cook University, Townsville, QLD, Australia.
- Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, QLD, Australia.
- Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, QLD, Australia.
- QIMR Berghofer Medical Research Institute, Herston, QLD, Australia.
- Australian Infectious Diseases Research Centre, University of Queensland, Brisbane, QLD, Australia.
ORCID-Profile: Timothy R McCulloch, Kyohei Nakamura, Fernando Souza-Fonseca-Guimaraes
Förderung
- National Health and Medical Research Council
- Diamantina Institute, University of Queensland
Zitieren
APA
McCulloch, T. R., Rossi, G. R., Miranda-Hernandez, S., Valencia-Hernandez, A. M., Alim, L., Belle, C. J., Krause, A., Zacchi, L. F., Lam, P. Y., Nakamura, K., Kupz, A., Wells, T. J., & Souza-Fonseca-Guimaraes, F. (2024). The immune checkpoint TIGIT is upregulated on T cells during bacterial infection and is a potential target for immunotherapy. Immunology & Cell Biology. https://doi.org/10.1111/imcb.12794
Vancouver
McCulloch TR, Rossi GR, Miranda-Hernandez S, Valencia-Hernandez AM, Alim L, Belle CJ, et al. The immune checkpoint TIGIT is upregulated on T cells during bacterial infection and is a potential target for immunotherapy. Immunology & Cell Biology. 2024. doi:10.1111/imcb.12794
BibTeX
@article{McCulloch2024,
author = {McCulloch, Timothy R and Rossi, Gustavo R and Miranda-Hernandez, Socorro and Valencia-Hernandez, Ana Maria and Alim, Louisa and Belle, Clemence J and Krause, Andrew and Zacchi, Lucia F and Lam, Pui Yeng and Nakamura, Kyohei and Kupz, Andreas and Wells, Timothy J and Souza-Fonseca-Guimaraes, Fernando},
title = {The immune checkpoint TIGIT is upregulated on T cells during bacterial infection and is a potential target for immunotherapy},
journal = {Immunology & Cell Biology},
year = {2024},
doi = {10.1111/imcb.12794}
}
EUVIMED